Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

64 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Scleroderma gene expression and pathway signatures.
Sargent JL, Milano A, Connolly MK, Whitfield ML. Sargent JL, et al. Among authors: connolly mk. Curr Rheumatol Rep. 2008 Jul;10(3):205-11. doi: 10.1007/s11926-008-0034-5. Curr Rheumatol Rep. 2008. PMID: 18638428 Review.
Systemic and cell type-specific gene expression patterns in scleroderma skin.
Whitfield ML, Finlay DR, Murray JI, Troyanskaya OG, Chi JT, Pergamenschikov A, McCalmont TH, Brown PO, Botstein D, Connolly MK. Whitfield ML, et al. Among authors: connolly mk. Proc Natl Acad Sci U S A. 2003 Oct 14;100(21):12319-24. doi: 10.1073/pnas.1635114100. Epub 2003 Oct 6. Proc Natl Acad Sci U S A. 2003. PMID: 14530402 Free PMC article.
The pathogenesis of systemic sclerosis.
Katsumoto TR, Whitfield ML, Connolly MK. Katsumoto TR, et al. Among authors: connolly mk. Annu Rev Pathol. 2011;6:509-37. doi: 10.1146/annurev-pathol-011110-130312. Annu Rev Pathol. 2011. PMID: 21090968 Review.
Molecular framework for response to imatinib mesylate in systemic sclerosis.
Chung L, Fiorentino DF, Benbarak MJ, Adler AS, Mariano MM, Paniagua RT, Milano A, Connolly MK, Ratiner BD, Wiskocil RL, Whitfield ML, Chang HY, Robinson WH. Chung L, et al. Among authors: connolly mk. Arthritis Rheum. 2009 Feb;60(2):584-91. doi: 10.1002/art.24221. Arthritis Rheum. 2009. PMID: 19180499 Free PMC article.
Intravenous versus oral cyclophosphamide for lung and/or skin fibrosis in systemic sclerosis: an indirect comparison from EUSTAR and randomised controlled trials.
Bruni C, Tashkin DP, Steen V, Allanore Y, Distler O, Grotts J, Matucci-Cerinic M, Furst DE; EUSTAR, SLS I & SLS II centres collaborators. Bruni C, et al. Clin Exp Rheumatol. 2020 May-Jun;38 Suppl 125(3):161-168. Epub 2020 Aug 27. Clin Exp Rheumatol. 2020. PMID: 32865169 Free article. Clinical Trial.
Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial.
Tashkin DP, Roth MD, Clements PJ, Furst DE, Khanna D, Kleerup EC, Goldin J, Arriola E, Volkmann ER, Kafaja S, Silver R, Steen V, Strange C, Wise R, Wigley F, Mayes M, Riley DJ, Hussain S, Assassi S, Hsu VM, Patel B, Phillips K, Martinez F, Golden J, Connolly MK, Varga J, Dematte J, Hinchcliff ME, Fischer A, Swigris J, Meehan R, Theodore A, Simms R, Volkov S, Schraufnagel DE, Scholand MB, Frech T, Molitor JA, Highland K, Read CA, Fritzler MJ, Kim GHJ, Tseng CH, Elashoff RM; Sclerodema Lung Study II Investigators. Tashkin DP, et al. Among authors: connolly mk. Lancet Respir Med. 2016 Sep;4(9):708-719. doi: 10.1016/S2213-2600(16)30152-7. Epub 2016 Jul 25. Lancet Respir Med. 2016. PMID: 27469583 Free PMC article. Clinical Trial.
Capillary regeneration in scleroderma: stem cell therapy reverses phenotype?
Fleming JN, Nash RA, McLeod DO, Fiorentino DF, Shulman HM, Connolly MK, Molitor JA, Henstorf G, Lafyatis R, Pritchard DK, Adams LD, Furst DE, Schwartz SM. Fleming JN, et al. Among authors: connolly mk. PLoS One. 2008 Jan 16;3(1):e1452. doi: 10.1371/journal.pone.0001452. PLoS One. 2008. PMID: 18197262 Free PMC article.
64 results